Professor | Yaojin Peng | Asia Growth Partners

Name	Yaojin Peng
Contact Information	yaojin.peng@ioz.ac.cn
Language ability	English, Chinese, German
Province	Beijing

Name

Yaojin Peng

Contact Information

yaojin.peng@ioz.ac.cn

Language ability

English, Chinese, German

Province

Beijing

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2013-09 to 2018-09 PhD: Maastricht University 2010-09 to 2013-07 Master's: Graduate School of Chinese Academy of Social Sciences 2005-09 to 2009-07 Bachelor's: University of Science and Technology Beijing
Work Experience	2018-12 to Present - Chinese Academy of Sciences, Institute of Zoology - Associate Researcher 2021-06-22 to Present - Director, Life Sciences and Medicine Subcommittee, CAS Committee on Science and Technology Ethics 2020-05-11 to Present - Member, ISO/TC276 Biotechnology Committee 2020-02-24 to Present - Visiting Researcher, Centre for AI and Law, Singapore Management University 2019-12-05 to Present - Researcher, Center for Bioethics, Huazhong University of Science and Technology 2019-11-14 to Present - Secretary-General, Ethics Working Committee, Chinese Society for Cell Biology 2019-09-08 to Present - Member, Expert Committee, National Stem Cell Resource Bank Innovation Alliance 2019-09-02 to Present - Deputy Director, Biomedical Ethics Committee, Institute of Zoology, Chinese Academy of Sciences

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2013-09 to 2018-09 PhD: Maastricht University
2010-09 to 2013-07 Master's: Graduate School of Chinese Academy of Social Sciences
2005-09 to 2009-07 Bachelor's: University of Science and Technology Beijing

Work Experience

2018-12 to Present - Chinese Academy of Sciences, Institute of Zoology - Associate Researcher
2021-06-22 to Present - Director, Life Sciences and Medicine Subcommittee, CAS Committee on Science and Technology Ethics
2020-05-11 to Present - Member, ISO/TC276 Biotechnology Committee
2020-02-24 to Present - Visiting Researcher, Centre for AI and Law, Singapore Management University
2019-12-05 to Present - Researcher, Center for Bioethics, Huazhong University of Science and Technology
2019-11-14 to Present - Secretary-General, Ethics Working Committee, Chinese Society for Cell Biology
2019-09-08 to Present - Member, Expert Committee, National Stem Cell Resource Bank Innovation Alliance
2019-09-02 to Present - Deputy Director, Biomedical Ethics Committee, Institute of Zoology, Chinese Academy of Sciences

Areas of Focus	Bioethics and Governance Science and Technology Policy and Management
Publications	The variability of judicial decisions in the stem cell industry in China, 11th Author, 2023 Technical specifications for ethics review of human stem cell research, 11th Author, 2023 人-动物嵌合体研究的技术-伦理张力, 11th Author, 2023 Acting on ethics and governance of aging research, 11th Author, 2023 人体生物样本知情同意退出制度重塑, 2nd Author, 2022 线粒体置换技术的挑战及其规制, 4th Author, 2022 A framework for the responsible reform of the 14-day rule in human embryo research, 11th Author, 2022 人类胚胎研究\"14天规则\"的挑战与出路, 1st Author, 2022 应对生物技术变革与伦理新挑战的中国方略, 1st Author, 2021 合成生物学时代：生物安全、生物安保与治理, 1st Author, 2020 Stem cell therapy advertisements in China: infodemic, regulations and recommendations, 11th Author, 2020 Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China, 11th Author, 2020 这是生物技术的时代，也是生物安全的时代, 2nd Author, 2020 生命科技伦理问题与治理策略——以人-动物嵌合体研究为例, 1st Author, 2020 “设计婴儿”：我们将怎样面对, 1st Author, 2019 Patent Term Extension in the Pharmaceutical Sector: An Asian Comparative Perspective, 1st Author, 2019 The morality and ethics governing CRISPR-Cas9 patents in China, 11th Author, 2016 中国干细胞知识产权保护的困境与对策, 1st Author, 2016 The patentability of human embryonic stem cell technology in China, 11th Author, 2016 PATENTING HUMAN EMBRYONIC STEM CELL RELATED INVENTIONS IN CHINA: A COMPARATIVE PERSPECTIVE, 1st Author, 2018

Areas of Focus

Bioethics and Governance
Science and Technology Policy and Management

Publications

The variability of judicial decisions in the stem cell industry in China, 11th Author, 2023
Technical specifications for ethics review of human stem cell research, 11th Author, 2023
人-动物嵌合体研究的技术-伦理张力, 11th Author, 2023
Acting on ethics and governance of aging research, 11th Author, 2023
人体生物样本知情同意退出制度重塑, 2nd Author, 2022
线粒体置换技术的挑战及其规制, 4th Author, 2022
A framework for the responsible reform of the 14-day rule in human embryo research, 11th Author, 2022
人类胚胎研究\"14天规则\"的挑战与出路, 1st Author, 2022
应对生物技术变革与伦理新挑战的中国方略, 1st Author, 2021
合成生物学时代：生物安全、生物安保与治理, 1st Author, 2020
Stem cell therapy advertisements in China: infodemic, regulations and recommendations, 11th Author, 2020
Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China, 11th Author, 2020
这是生物技术的时代，也是生物安全的时代, 2nd Author, 2020
生命科技伦理问题与治理策略——以人-动物嵌合体研究为例, 1st Author, 2020
“设计婴儿”：我们将怎样面对, 1st Author, 2019
Patent Term Extension in the Pharmaceutical Sector: An Asian Comparative Perspective, 1st Author, 2019
The morality and ethics governing CRISPR-Cas9 patents in China, 11th Author, 2016
中国干细胞知识产权保护的困境与对策, 1st Author, 2016
The patentability of human embryonic stem cell technology in China, 11th Author, 2016
PATENTING HUMAN EMBRYONIC STEM CELL RELATED INVENTIONS IN CHINA: A COMPARATIVE PERSPECTIVE, 1st Author, 2018

Bioethics Governance Stem Cells Ethics Review Human Embryo Research Mitochondrial Replacement Synthetic Biology Biotechnology Biosafety Biosecurity

Xiong Yan - University of Chinese Academy of Sciences

Liu Wang - University of Chinese Academy of Sciences

Wenbing Yin - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us